Literature DB >> 21390053

State of the union between metabolism and the immune system in type 2 diabetes.

B S Nikolajczyk1, M Jagannathan-Bogdan, H Shin, R Gyurko.   

Abstract

Lymphocytes and myeloid cells (monocyte/macrophages) have important roles in multiple types of diseases characterized by unresolved inflammation. The relatively recent appreciation of obesity, insulin resistance and type 2 diabetes (T2D) as chronic inflammatory diseases has stimulated interest in understanding the role of immune cells in metabolic imbalance. Myeloid cells regulate inflammation through cytokine production and the adipose tissue remodeling that accompanies hyper-nutrition, thus are critical players in metabolic homeostasis. More recently, multiple studies have indicated a role for T cells in obesity-associated inflammation and insulin resistance in model organisms, with parallel work indicating that pro-inflammatory changes in T cells also associate with human T2D. Furthermore, the expansion of T cells with similar antigen-binding sites in obesity and T2D indicates these diseases share characteristics previously attributed to inflammatory autoimmune disorders. Parallel pro-inflammatory changes in the B-cell compartment of T2D patients have also been identified. Taken together, these studies indicate that in addition to accepted pro-inflammatory roles of myeloid cells in T2D, pro-inflammatory skewing of both major lymphocyte subsets has an important role in T2D disease pathogenesis. Basic immunological principles suggest that alterations in lymphocyte function in obesity and T2D patients are an integral part of a feed-forward pro-inflammatory loop involving additional cell types. Importantly, the pro-inflammatory loop almost inevitably includes adipocytes, known to respond to pro-inflammatory, pro-diabetogenic cytokines originating from the myeloid and lymphoid compartments. We propose a model for inflammation in T2D that functionally links lymphocyte, myeloid and adipocyte contributions, and importantly proposes that tools for B-cell ablation or regulation of T-cell subset balance may have a place in the endocrinologist's limited arsenal.

Entities:  

Mesh:

Year:  2011        PMID: 21390053      PMCID: PMC6826342          DOI: 10.1038/gene.2011.14

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  145 in total

1.  IL-17 regulates adipogenesis, glucose homeostasis, and obesity.

Authors:  Luis A Zúñiga; Wen-Jun Shen; Barbara Joyce-Shaikh; Ekaterina A Pyatnova; Andrew G Richards; Colin Thom; Sofia M Andrade; Daniel J Cua; Fredric B Kraemer; Eugene C Butcher
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

Review 2.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

3.  Molecular mechanisms responsible for endotoxin tolerance.

Authors:  B Yoza; K LaRue; C McCall
Journal:  Prog Clin Biol Res       Date:  1998

4.  IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells.

Authors:  C Y Wu; C Demeure; M Kiniwa; M Gately; G Delespesse
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

5.  Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.

Authors:  J C Pickup; G D Chusney; S M Thomas; D Burt
Journal:  Life Sci       Date:  2000-06-08       Impact factor: 5.037

6.  Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes.

Authors:  W Lee Hand; Debra L Hand; Yvonne Vasquez
Journal:  Diabetes Res Clin Pract       Date:  2006-09-07       Impact factor: 5.602

7.  Interleukin-6 autoantibodies are involved in the pathogenesis of a subset of type 2 diabetes.

Authors:  K Fosgerau; P Galle; T Hansen; A Albrechtsen; C de Lemos Rieper; B Klarlund Pedersen; L Kongskov Larsen; A Randrup Thomsen; O Pedersen; M Bagge Hansen; A Steensberg
Journal:  J Endocrinol       Date:  2009-12-16       Impact factor: 4.286

8.  Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice.

Authors:  K R Coenen; M L Gruen; R S Lee-Young; M J Puglisi; D H Wasserman; A H Hasty
Journal:  Diabetologia       Date:  2008-12-04       Impact factor: 10.122

9.  Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity.

Authors:  O Osborn; S E Brownell; M Sanchez-Alavez; D Salomon; H Gram; T Bartfai
Journal:  Cytokine       Date:  2008-08-23       Impact factor: 3.861

10.  GAD antibody positivity predicts type 2 diabetes in an adult population.

Authors:  Virve M Lundgren; Bo Isomaa; Valeriya Lyssenko; Esa Laurila; Pasi Korhonen; Leif C Groop; Tiinamaija Tuomi
Journal:  Diabetes       Date:  2009-10-28       Impact factor: 9.461

View more
  54 in total

1.  Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.

Authors:  Nathella P Kumar; Rathinam Sridhar; Dina Nair; Vaithilingam V Banurekha; Thomas B Nutman; Subash Babu
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

Review 2.  B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.

Authors:  Daniel A Winer; Shawn Winer; Melissa H Y Chng; Lei Shen; Edgar G Engleman
Journal:  Cell Mol Life Sci       Date:  2013-10-15       Impact factor: 9.261

3.  Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response.

Authors:  Xiao-Qun Han; Zuo-Jiong Gong; San-Qing Xu; Xun Li; Li-Kun Wang; Shi-Min Wu; Jian-Hong Wu; Hua-Fen Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

Review 4.  Diabetes mellitus and inflammation.

Authors:  Eric Lontchi-Yimagou; Eugene Sobngwi; Tandi E Matsha; Andre Pascal Kengne
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

Review 5.  Convergence of non-communicable diseases and tuberculosis: a two-way street?

Authors:  M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

6.  Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus.

Authors:  Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Subash Babu
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

7.  Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Nicholas V Mendez; Ana Marie Landin; John G Ryan; Bonnie B Blomberg
Journal:  Vaccine       Date:  2013-05-25       Impact factor: 3.641

8.  Adiponectin and IL-6: Mediators of inflammation in progression of healthy to type 2 diabetes in Indian population.

Authors:  Smitha Upadhyaya; Vinitha Kadamkode; Rafi Mahammed; Chandraprabha Doraiswami; Gautam Banerjee
Journal:  Adipocyte       Date:  2013-10-08       Impact factor: 4.534

9.  Therapeutic potential of human embryonic stem cells in type 2 diabetes mellitus.

Authors:  Geeta Shroff
Journal:  World J Stem Cells       Date:  2016-07-26       Impact factor: 5.326

Review 10.  Diabetes and Its Effect on Bone and Fracture Healing.

Authors:  Hongli Jiao; E Xiao; Dana T Graves
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.